Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.25
Bid: 16.00
Ask: 16.50
Change: -0.50 (-2.99%)
Spread: 0.50 (3.125%)
Open: 16.75
High: 16.25
Low: 14.80
Prev. Close: 16.75
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Dianomi swings to loss; Epwin revenue up

Wed, 20th Sep 2023 14:27

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Epwin Group PLC - Solihull, England-based building products manufacturer - Revenue in six months to June 30 up 1.1% to GBP180.0 million from GBP178.0 million. Pretax profit flat at GBP7.9 million. Interim dividend per share rises 5.3% to 2.0 pence from 1.9p a year prior. "Q3 trading to date has been encouraging with profitability ahead of 2022," Epwin adds. It expects to report annual results in line with market expectations. Underlying operating profit expectations stand at GBP24.0 million, which would represent a 12% rise from GBP21.5 million in 2022.

----------

Dianomi PLC - London-based digital advertising platform - Revenue in half-year ended June 30 drops 18% to GBP14.8 million from GBP18.0 million, amid "decline in traffic volumes across the group's direct publisher inventory". Swings to pretax loss of GBP2.1 million from profit of GBP897,000 a year earlier. "We are mindful of an environment that continues to be challenging and the need to adapt. The group's operational cost base has been streamlined and optimised following the restructuring of the group's global management and sales teams, resulting in an annualised cost reduction of GBP1 million. However, in spite of a difficult backdrop, I am pleased to report that Dianomi continues to attract new clients and now counts all 10 of the top 10 US asset managers as clients," Chief Executive Rupert Hodson says. Dianomi expects a profitable second-half. In addition, the firm explained it has agreed a contract amendment with "one of its largest and longest standing publisher partners". While bullish that the amendment is good news in the long-term, Dianomi noted the arrangement hurt its adjusted earnings before, interest, tax, depreciation and amortisation for the six months of 2023. "There will be a short-term impact on cash of GBP500,000 in the current financial year which will unwind during 2024," the firm says. Dianomi says minimum traffic levels were not met, meaning it was overpaid by the publisher to tune of USD1 million. Dianomi adds: "Following discussions, the company and the publisher have entered into an amendment to the agreement whereby Dianomi has agreed not to recoup the overpayment, in return for which the publisher will provide Dianomi with an enhanced revenue share as from 1 July 2023 and, in addition to its existing permanent ad units, will provide Dianomi with additional premium ad inventory, including a new in-article unit."

----------

Ten Entertainment Group PLC - ten-pin bowling operator - Total sales in half-year ended July 2 improve 3.3% on-year to GBP65.3 million from GBP63.2 million a year earlier. Pretax profit, however, falls by a quarter to GBP15.8 million from GBP21.0 million. The prior year's bottom line got a GBP4.4 million boost from a claim for reduced rate of VAT on bowling. Ten Entertainment adds: "An ongoing focus on refurbishment, customer service and digital communications gives us confidence that we can continue to deliver like-for-like sales growth from the existing estate through addition of new activities and focus on the core entertainment experience. Cost inflation remains manageable, and we expect a slightly lower than the UK headline rate as a function of our long-term supplier strategy." The firm adds year-to-date like-for-like sales are 4.7% higher.

----------

DP Aircraft I Ltd - Guernsey-based aircraft leasing company - Lease rental in six months to June 30 falls 43% to USD4.3 million from USD7.6 million a year earlier. DP Aircraft swings to a pretax loss of USD4.1 million from profit of USD3.0 million. "There has been a continued improvement in the global aviation market following the challenges resulting from the effects of the Covid-19 pandemic. Recent sentiment on airline and related stocks has been more optimistic. The Ukraine war has not had as significant an impact on the industry as expected. With Covid-19 restrictions in China being lifted there is cause for some optimism in tourism numbers from that market in Thailand going forward," DP Aircraft says.

----------

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Reports licence fee income of GBP831,552 in first half ended June 30, against none a year earlier. Pretax loss narrows to GBP3.1 million from GBP3.8 million. CEO Chris Tovey says: "The partnering of NTCD-M3 and the associated fundraising during the period demonstrate our ability to generate significant value from our assets, and have positioned the company for success as we advance the Phase 3 development programme for M3 and intensify our partnering activities for our lead asset, XF-73 nasal. The company is now funded through to Q1 2025, allowing us to deliver our planned activities."

----------

Ethernity Networks Ltd - supplier of data processing semiconductor technology for networking appliances - Revenue in first half ended June 30 surges 98% to USD1.4 million from USD704,853. Pretax loss, however, widens to USD3.6 million from USD3.5 million. Reports financing income of just GBP322,814, down from GBP1.2 million a year earlier. Ethernity adds: "The company is targeting the achievement of positive cash flow generation from operations during the second half of 2023 by continuing to fulfil customers' orders and from anticipated revenue from new contracts, in combination with a reduction in expenses."

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
25 Apr 2024 20:57

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Apr 2024 10:23

AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
31 Jan 2024 18:28

EARNINGS AND TRADING: STV raises holding in Two Cities Television

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
4 Jan 2024 14:07

Destiny Pharma seeks to capitalise on XF-73 market potential in 2024

(Alliance News) - Destiny Pharma PLC on Thursday said that its priority remains promoting its XF-73 Nasal antibacterial drug.

Read more
4 Jan 2024 11:27

Destiny Pharma reports progress on clinical assets

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma said in a year-end update on Thursday that its primary focus remained on realising the full potential of its XF-73 Nasal asset.

Read more
29 Oct 2023 21:01

Sunday share tips: Destiny Pharma, Invinity Energy Systems

(Sharecast News) - The Financial Mail on Sunday's Midas column spied long-term potential in Destiny Pharma's shares.

Read more
17 Oct 2023 11:15

Destiny Pharma celebrates study findings on "potent" flagship drug

(Alliance News) - Destiny Pharma PLC shares soared on Tuesday after new data showed XF-73, its leading antibacterial drug, to be effective against over 2,500 Staphylococcus isolates, including resistant strains.

Read more
17 Oct 2023 10:18

AIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 data

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
13 Sep 2023 15:48

UK earnings, trading statements calendar - next 7 days

Thursday 14 September 
Arecor Therapeutics PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Capricorn Energy PLCHalf Year Results
Checkit PLCHalf Year Results
Churchill China PLCHalf Year Results
Foresight Solar Fund LtdHalf Year Results
Glenveagh Properties PLCHalf Year Results
IG Group Holdings PLCTrading Statement
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
M&C Saatchi PLCHalf Year Results
MJ Gleeson PLCFull Year Results
Oakley Capital Investments LtdHalf Year Results
Renishaw PLCFull Year Results
Spire Healthcare Group PLCHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Uniphar PLCHalf Year Results
Friday 15 September 
Petra Diamonds LtdFull Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Monday 18 September 
Artisanal Spirits Co PLCHalf Year Results
City of London Investment Group PLCFull Year Results
Downing Renewables & Infrastructure Trust PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Futura Medical PLCHalf Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Phoenix Group Holdings PLCHalf Year Results
S4 Capital PLCHalf Year Results
Tuesday 19 September 
accesso Technology Group PLCHalf Year Results
Billington Holdings PLCHalf Year Results
Big Technologies PLCHalf Year Results
C&C Group PLCTrading Statement
Concurrent Technologies PLCHalf Year Results
CPPGroup PLCHalf Year Results
Eagle Eye Solutions Group PLCFull Year Results
Fintel PLCHalf Year Results
Good Energy Group PLCHalf Year Results
Hargreaves Lansdown PLCFull Year Results
Henry Boot PLCHalf Year Results
Kingfisher PLCHalf Year Results
Litigation Capital Management LtdFull Year Results
Maintel Holdings PLCHalf Year Results
McBride PLCFull Year Results
MyHealthChecked PLCHalf Year Results
Moonpig Group PLCTrading Statement
Naked Wines PLCFull Year Results
Northcoders Group PLCHalf Year Results
Ocado Group PLCTrading Statement
Serica Energy PLCHalf Year Results
SThree PLCTrading Statement
Surgical Innovations Group PLCHalf Year Results
Team17 Group PLCHalf Year Results
Trustpilot Group PLCHalf Year Results
Water Intelligence PLCHalf Year Results
Xaar PLCHalf Year Results
Wednesday 20 September 
Advanced Medical Solutions Group PLCHalf Year Results
ASA International Group PLCHalf Year Results
Destiny Pharma PLCHalf Year Results
Dunelm Group PLCTrading Statement
Epwin Group PLCHalf Year Results
Galliford Try Holdings PLCFull Year Results
GENinCode PLCHalf Year Results
HydrogenOne Capital Growth PLCHalf Year Results
Judges Scientific PLCHalf Year Results
LBG Media PLCHalf Year Results
M&G PLCHalf Year Results
Oxford Biomedica PLCHalf Year Results
PYX Resources LtdHalf Year Results
Round Hill Music Royalty Fund LtdHalf Year Results
Supermarket Income REIT PLCFull Year Results
Ten Entertainment Group PLCHalf Year Results
Warpaint London PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
31 Jul 2023 17:31

TRADING UPDATES: MGC Pharmaceuticals granted psilocybin import permit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
25 Jul 2023 14:27

IN BRIEF: Destiny Pharma says former Chair Nigel Rudd return to role

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Says Nigel Rudd will be returning as chair, effective immediately. He was chair of Destiny from 2010 to 2018, and led its flotation on the London AIM market.

Read more
19 Jul 2023 13:16

IN BRIEF: Destiny Pharma appoints Chris Tovey as CEO; Chair resigns

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Appoints Chris Tovey as chief executive officer from September 1, taking over from Interim CEO Debra Barker who will return to position of non-executive director. The company announces departure of Chair Nick Rodgers, expects to announce new outside chair shortly.

Read more
6 Jul 2023 12:49

IN BRIEF: Destiny Pharma confirms phase 3 development for lead asset

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Confirms proposed phase three development pathway and identifies new life cycle management targets for its XF-73 Nasal programme. Says antimicrobial properties of XF-73 Nasal give greater flexibility in the scheduling of surgeries. Adds there is potential to explore new life management indications, particularly in children.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.